Author

Robin Fabre

Observed name: R. Fabre

Institution: GlaxoSmithKline (Belgium)

Observed institution: GlaxoSmithKline (Belgium)

OpenAlex ID: A5019784672

Sustained efficacy of the RTS,S/AS01E malaria vaccine over 50 months of follow-up when used in full-dose or fractional-dose regimens in young children in Ghana and Kenya: final results from an open-label, phase 2b, randomised controlled trial

2025 · Lawrence Osei-Tutu, Simon K Kariuki, et al. · The Lancet Global Health · 3

C-02 - Infections versus colonisations urinaires masculines à entérocoque

2013 · L. Chauffrey, M. Pestel-Caron, et al.

Works count: 2

Citation count: 3

H-index: 1

I10-index: